Perez de la Cruz Moreno Mariangeles, Oth Marianne, Deferme Sven, Lammert Frank, Tack Jan, Dressman Jennifer, Augustijns Patrick
Laboratory for Pharmacotechnology and Biopharmacy, O&N Gasthuisberg, Catholic University of Leuven, Belgium.
J Pharm Pharmacol. 2006 Aug;58(8):1079-89. doi: 10.1211/jpp.58.8.0009.
The solubility of drugs in the gastrointestinal tract is very challenging to simulate with artificial media due to the high complexity of human intestinal fluid (HIF). In particular, bile salt composition, pH and buffer capacity are very important characteristics of HIF, since they determine the solubility of drugs in-vivo. In this study, we have measured the concentrations of individual bile salts in human intestinal fluids (n=6) collected from two different locations (duodenum and jejunum) in the fasted state. Total bile salt concentrations ranged from 570 to 5,137 microM in the duodenum and from 829 to 5,470 microM in the jejunum. The following rank order of relative bile salt concentration in duodenum was observed: taurocholic acid > glycocholate >or= glycochenodeoxycholate > glycodeoxycholate > taurochenodeoxycholate > taurodeoxycholate. Cholic acid, tauroursodeoxycholate, chenodeoxycholic acid, and deoxycholic acid represented less than 1% of bile salts present in the samples. Ursodeoxycholate could not be detected in HIF. No statistically significant difference between bile salt composition of duodenal and jejunal aspirates was observed. The buffer capacity of HIF was compared with other media commonly used for solubility/dissolution determinations, indicating a relatively low buffer capacity of HIF (4-13 mmol L(-1)/pH). This low buffer capacity was reflected in the change in pH (between 4 and 9.5) that occurred in HIF after addition of model compounds covering a broad pK(a) range. Interindividual variability in pH, buffer capacity and bile salt contents of HIF will contribute to differences in the rate and extent of absorption of compounds for which dissolution/solubility is the rate limiting step. The variability observed warrants further research to explore the impact of intraluminal conditions on drug solubility.
由于人体肠液(HIF)高度复杂,利用人工介质模拟药物在胃肠道中的溶解度极具挑战性。特别是,胆汁盐组成、pH值和缓冲能力是HIF的非常重要的特性,因为它们决定了药物在体内的溶解度。在本研究中,我们测定了在禁食状态下从两个不同位置(十二指肠和空肠)采集的人体肠液(n = 6)中各胆汁盐的浓度。十二指肠中总胆汁盐浓度范围为570至5137微摩尔/升,空肠中为829至5470微摩尔/升。观察到十二指肠中胆汁盐相对浓度的以下排序:牛磺胆酸>甘氨胆酸≥甘氨鹅脱氧胆酸>甘氨脱氧胆酸>牛磺鹅脱氧胆酸>牛磺脱氧胆酸。胆酸、牛磺熊去氧胆酸、鹅去氧胆酸和脱氧胆酸占样品中胆汁盐的比例不到1%。在HIF中未检测到熊去氧胆酸盐。未观察到十二指肠和空肠吸出物的胆汁盐组成之间存在统计学显著差异。将HIF的缓冲能力与常用于溶解度/溶出度测定的其他介质进行了比较,结果表明HIF缓冲能力相对较低(4 - 13毫摩尔/升/pH)。这种低缓冲能力反映在加入涵盖广泛pKa范围的模型化合物后HIF中发生的pH变化(4至9.5之间)。HIF的pH值、缓冲能力和胆汁盐含量的个体间差异将导致对于溶解/溶解度是限速步骤的化合物,其吸收速率和程度存在差异。观察到的变异性值得进一步研究,以探索肠腔内条件对药物溶解度的影响。